Synonyms: 2-(1,3,4-Oxadiazol-2-yl)phenol; 1008-65-7; J. L. 512; 2-(1,3,4-oxadiazol-2-yl)benzenol; 2-(o-Hydroxyphenyl)-1,3,4-oxadiazole; Fenadiazole [INN:DCF]; UNII-8YX6HIZ0IP; Fenadiazol [INN-Spanish]; Fenadiazolum [INN-Latin]; NSC 100729; PHENOL, 2-(1,3,4-OXADIAZOL-2-YL)-; 1,3,4-Oxadiazole, 2-(o-hydroxyphenyl)-; Fenadiazole; 8YX6HIZ0IP; Phenol, o-1,3,4-oxadiazol-2-yl-; BRN 0136925; MLS002703546; OINXXHYENYVYPB-UHFFFAOYSA-N; JL-512; MFCD00020713; ACMC-1BZDH; AC1NSE2D; AC1NTGD2; Fenadiazol; AC1O9VRQ; DSSTox_CID_31397; DSSTox_RID_97283; DSSTox_GSID_57608; 4-27-00-07344 (Beilstein Handbook Reference); o-1,4-Oxadiazol-2-ylphenol; SCHEMBL555484; Phenol,3,4-oxadiazol-2-yl-; AC1Q788K; IFLab1_006238; Eudormil; IFLab2_000252; ZINC1423; CHEMBL1903897; DTXSID7057608; Phenol,3,4-oxadiazol-2-yl)-; CTK3J6765; KS-00001QCH; o-1,3,4-Oxodiazol-2-ylphenol; 2-(1,4-Oxadiazol-2-yl)phenol; CHEBI:134791; Hypnazol; HMS1429L12; Tox21_113759; 0284AA; ANW-55011; NSC100729; ODZ100103; SBB041007; STK409833; 2-(o-Hydroxyphenyl)-1,4-oxadiazole; ortho-1,3,4-Oxadiazol-2-yl-phenol; Viodor; 2-(1,3,4-Oxadiazol-2-yl)-phenol; AKOS000269733; MCULE-5839956801; NE32146; NSC-100729; RP10242; RTR-000262; SDCCGMLS-0065586.P001; IDI1_019278; 1,4-Oxadiazole, 2-(o-hydroxyphenyl)-; Fenadiazolum; 2-(2-hydroxyphenyl)-1,3,4-oxadiazole; NCGC00253631-01; AJ-08024; SMR001570263; ZB000331; ZB000332; CAS-1008-65-7; DB-058510; LS-105017; TR-000262; JL 512; FT-0608353; Phenol, o-1,3,4-oxadiazol-2-yl- (8CI); ST24039033; ST50107712; 10A-002; AT-057/42646623; J-505292; BRD-K18362446-001-06-8; I01-15995; 6-(3H-1,3,4-oxadiazol-2-ylidene)cyclohexa-2,4-dien-1-one; o-1,3,4-Oxadiazol-2-ylphenol; (6E)-6-(3H-1,3,4-oxadiazol-2-ylidene)cyclohexa-2,4-dien-1-one; (6Z)-6-(3H-1,3,4-oxadiazol-2-ylidene)cyclohexa-2,4-dien-1-one; Fenadiazole [DCF:INN]; C8H6N2O2; C8-H6-N2-O2; CID5359546; CID5380573; CID6738087;